News

Vor Bio is the latest cell therapy company to reach the end of the road. | Vor Bio is the latest cell therapy company to ...
The 27,000-square-foot center will serve as a hub for advanced livestock reproduction research, education, and outreach, ...
BeiGene aims to be a next-generation oncology innovator by broadening its drug and pipeline portfolio to various solid tumors in addition to blood cancers. As such, it been actively investing to build ...
Korro Bio is laying off a fifth of its workforce as the Novo Nordisk-partnered biotech funnels resources to its ...
Dive deeper with STAT+. Gain unlimited access to expert analysis, newsletters, events, and news alerts.
Trump’s tariffs and the trade war with China continue to impact global markets. Follow along for live updates on the Dow, S&P 500 and Nasdaq.
“Today’s cut to interest rates was widely anticipated, underscoring the Monetary Policy Committee’s continued preference for ...
The FDA's decision to appoint Vinay Prasad, MD, MPH, to head its Center for Biologics Evaluation and Research (CBER) raised ...
Cadence Design Systems unveiled on Wednesday a new supercomputer based on chips from Nvidia that will speed up its software ...
Moderna is being audited by the PMCPA after yet again being found to have brought discredit on the pharma industry, putting the company on a path that could lead to its suspension from U. | Moderna is ...
Techne's Q3 2025 earnings call, including 6% organic growth, FDA-driven opportunities, and strategies to tackle NIH funding & ...
MassBio’s new report outlines several concerns, including NIH cuts undermining the research engine, FDA reductions delaying ...